Important Announcement: 'Pause' in Human Subjects Research-Coronavirus Update
The ‘PAUSE’ in most human subjects research activities involving in-person, face-to-face interactions effected on March 16, 2020 has been extended until further notice -- unless canceling or postponing the interaction increases the risk to a research participant’s safety or well-being.
If you have further questions, we encourage you to reach out to us by emailing Susan DeMocker, Associate Director of Research Protections, at email@example.com.
Research Operations Continuity: Restart Guidance for Laboratory Principal Investigators and Lab Directors
The Research Operations Continuity Guide (PDF) is provided to assist researchers in their lab-specific preparations for bringing their research laboratories back online from temporary shutdown.
NIH-Wide Strategic Plan for COVID-19 Research Now Available
2021 NIH-Wide COVID-19 Strategic Plan outlines NIH plans to address the most recent challenges of COVID-19, such as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), or Long COVID, and SARS-CoV-2 variants.
The Office of Research holds weekly office hours (PDF) on Wendesdays 12:30 p.m.–1:30 p.m. to address questions related to grant resources and grant application process.
We also hold IRB Virtual Office Hours via zoom twice weekly to help answer questions from study teams. The virtual office hours will begin the week of 8/17/2020 and are currently planned to run through the week of 9/14/2020, with additional sessions added if needed. Pace Principal Investigators and study team members interested in joining a virtual office hour session may submit an email request to firstname.lastname@example.org. Study team members may sign up for one-time slot. Sessions are capped at 15 attendees. Once you have registered, an email confirming zoom details will be provided. Dates and times for upcoming sessions are:
- Tuesdays 10:00 a.m.–10:55 a.m. and 11:05 a.m.–12:00 p.m.
- Thursdays 12:00 p.m.–12:55 p.m. and 1:05 p.m.–2:00 p.m.
The Office of Research has completed the beta-testing phase of the new PaceHeatlh Platform and is rolling it out to our Pace community of researchers and clinicians.
PaceHealth is a new type of Zoom account that provides a HIPAA-compliant platform while utilizing the resources and hardware that you already have to expand your research capabilities and telehealth offerings.
If you are would like to migrate your current Zoom account to PaceHealth, here is some important information for you to know:
- All video streaming with patients that fall under HIPAA must ONLY be conducted from a PaceHealth Zoom account;
- Once an account has been migrated over to PaceHealth, it may not be migrated back to be a regular Zoom account;
- PaceHealth requires Pace accounts to use Duo multifactor authentication (MFA) to login. Research participants and patients will not require a MFA;
- All users that schedule Zoom meetings should be the first users moved over to PaceHealth;
- Users that are migrated over to PaceHealth will need to recreate the “Schedule Privilege” settings to allow the designated users to schedule meetings on their behalf;
- Any Zoom videos that are currently stored in the cloud will not be transferred over to the PaceHealth Account;
- PaceHealth videos will not be able to be recorded in the cloud;
- On the day of migration, all users will receive an email and will need to acknowledge and click on a link to move their account over to PaceHealth;
- Previously scheduled meeting URLs will automatically be redirected to its new PaceHealth URL;
- Once migrated, users will be able to access PaceHealth directly to login.
Additional PaceHealth Information
- PaceHeatlh continues to encrypt all streaming video sessions.
If you are interested in learning more, or would like to be schedule a time to migrate your Zoom account to the PaceHealth, please email to Susan DeMocker at email@example.com.
Pace Small Business Development Center
The Pace Small Business Development Center (SBDC) business advisors are offering virtual 1:1 sessions.
The Center also hosts a dedicated webpage for COVID-19 programming.
Guidelines for Faculty and Student Laboratory Research at Pace University
The response to the Coronavirus pandemic is leading to a global restructuring of how we interact with each other and with our institutions. This impacts the research enterprise especially in the laboratory sciences. The following guidelines, effective immediately, are designed for faculty and students as we attempt to protect ourselves and our communities.
Coronavirus Updates from Federal Agencies for Researchers
Centers for Disease Control and Prevention (CDC):
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
CDC Funding Opportunities Specific to Coronavirus (COVID-19)
- Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
- Strengthening Global Field Epidemiology Training Program (FETP) Network
- Global Health Security Partner Enhancement : Expanding Efforts to Improve Surveillance and Laboratory Data Interoperability
- Building Capacity for National Public Health Institutes
- Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally
Council on Government Relations (COGR):
- Council on Government Relations (COGR) FAQ Regarding COVID-19's Impact on Federal Awards (Version 2.2) (PDF)
Department of Energy (DOE:
National Institute of Health (NIH):
- NEW: Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients
- NIH Extramural Response to Natural Disasters and Other Emergencies
- NOT-OD-20-082; NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- NOT-OD-20-083; General Frequently Asked Questions (FAQ) - Proposal Submission and Award Management Related to COVID-19
- Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
- Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
National Science Foundation (NSF):
- Coronavirus Information
- RAPID Research on Coronavirus (COVID-19) (PDF)
- Frequently Asked Questions (FAQ) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees
NSF Funding Opportunities Specific to Coronavirus (COVID-19)
- DCL on the Coronavirus Disease 2019 (COVID-19)
- DCL: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)